Key Takeaway: Compass Pathways plc will participate in the 2026 Cantor Global Healthcare Conference on September 9, 2026. The company will host a fireside chat and join a panel discussing psychedelics in mental health treatment. This engagement underscores their commitment to exploring new therapeutic options.
Price reaction · baseline $13.51 (2026-08-31 close) · hit pre-market · clean, no other CMPS news in the window
day 0 close · peak
-2%
Market Sentiment Analysis
POSITIVE FACTORS
Compass Pathways is actively engaging in important healthcare discussions.
Participation in the conference highlights the company's commitment to mental health.
The focus on psychedelics represents a growing interest in innovative treatment options.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~32 mo
Minimal dilution risk
Lead asset
Psilocybin
Phase 3 · Major Depressive Disorder
Full Press Release Details
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the 2026 Cantor Global Healthcare Conference on September 9, 2026 and will participate in a fireside chat at 3:20pm ET and a panel entitled “PSYCH! Accessing The New Wave of Psychedelics” at 4:30pm ET. A live audio webcast of the fireside chat will be accessible from the “E
Frequently Asked Questions
When is the 2026 Cantor Global Healthcare Conference?
The conference is scheduled for September 9, 2026.
What will Compass Pathways discuss at the conference?
They will participate in a fireside chat and a panel on psychedelics.
What time is the fireside chat at the conference?
The fireside chat is set for 3:20 PM ET.
What is the focus of the panel discussion?
The panel is titled 'PSYCH! Accessing The New Wave of Psychedelics.'